Tech Company Financing Transactions
Actimis Pharmaceuticals Funding Round
Private investors participated in a $452 thousand capital raise for Actimis Pharmaceuticals. This venture round was announced on 6/20/2017.
Transaction Overview
Company Name
Announced On
6/20/2017
Transaction Type
Debt
Amount
$452,001
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. 5 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
10835 Road to the Cure 200
San Diego, CA 92121
USA
San Diego, CA 92121
USA
Phone
Website
Email Address
Not Recorded
Overview
Actimis Pharmaceuticals is a biopharmaceutical company developing small molecule therapeutics for respiratory and inflammatory disorders.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Founder
Kevin Bacon
Browse more venture capital transactions:
Prev: 6/20/2017: Hero K12 venture capital transaction
Next: 6/20/2017: Technori venture capital transaction
Share this article
About Our VC Transactions Data
Our team works diligently to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs